Human Hyalohyphomycoses: A Review of Human Infections Due to Acremonium spp., Paecilomyces spp., Penicillium spp., and Scopulariopsis spp.

Journal of Chemotherapy

Volumn 15, Issue SUPPL. 2, 2003, Pages 5-15

  Schinabeck, M K ^a   Ghannoum, M A ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

Acremonium spp; Fungal infection; Human infection; Hyalohyphomycosis; Paecilomyces spp; Penicillium spp; Scopulariopsis spp; Treatment of fungal infection

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; ANIDULAFUNGIN; CASPOFUNGIN; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; KETOCONAZOLE; MICONAZOLE; POSACONAZOLE; PYRROLE DERIVATIVE; RAVUCONAZOLE; TERBINAFINE; VORICONAZOLE;

ACREMONIUM; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ANTIFUNGAL ACTIVITY; CLINICAL FEATURE; CLINICAL TRIAL; DEVICE; DRUG EFFICACY; EYE INFECTION; FUNGUS; HUMAN; HYALOHYPHOMYCOSIS; IMMUNE DEFICIENCY; INDWELLING CATHETER; INDWELLING MEDICAL DEVICE; MINIMUM INHIBITORY CONCENTRATION; MYCETOMA; MYCOLOGY; MYCOSIS; OPPORTUNISTIC INFECTION; PAECILOMYCES; PENICILLIUM; PENICILLIUM MARNEFFEI; RECURRENT INFECTION; REVIEW; SCOPULARIOPSIS;

EID: 0348140623     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2003.15.supplement-2.5     Document Type: Review

References (86)

1. Ajello L. Hyalohyphomycosis and phaeohyphomycosis: Two global disease entities of public health importance. Eur J Epidemiol 1986; 2(4): 243-251.
2. Padhye A.A. Hyalohyphomycosis. In: Balows A, Hausler WJ, Ohashi M, Turano A, editors. Laboratory Diagnosis of Infectious Diseases. Principles and Practices. Vol. 1. Bacterial, Mycotic, and Parasitic Diseases. New York: Springer-Verlag, 1988: 654-662.
3. Kennedy MJ, Sigler L. Aspergillus, Fusarium, and other opportunistic Moniliaceous fungi. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RN, editors. Manual of Clinical Microbiology. Washington, D.C.: American Society for Microbiology, 1995: 765-790.
4. Fincher RE, Fisher JF, Lovell RD, Newman CL, Espinel-Ingroff A, Shadomy HJ. Infection due to the fungus Acremonium (Cephalosporium). Medicine 1991; 70(6): 398-409.
5. Guarro J, Gams W, Pujol I, Gene J. Acremonium species: new emerging fungal opportunists - in vitro antifungal susceptibilities and review. Clin Infect Dis 1997; 25: 1222-1229.
6. Jeffrey WR, Hernandez JE, Zarraga AL, Oley GE, Kitchen LW. Disseminated infection due to Acremonium species in a patient with Addison's disease. Clin Infect Dis 1993; 16: 170.
7. Read RW, Chuck RSH, Rao NA, Smith RE. Traumatic Acremonium atrogriseum keratitis following laser-assisted in situ keratomileusis. Arch Ophthalmol 2000; 118: 418-421.
8. Kennedy SM, Shankland GS, Lee WR, Sekundo W. Keratitis due to the fungus Acremonium (Cephalosporium). Eye 1994; 8: 692-694.
9. Weissgold DJ, Maguire AM, Brucker AJ. Management of postoperative Acremonium endophthalmitis. Ophthalmology 1996; 103: 749-756.
10. Mascarenhas MR, McGowan KL, Ruchelli E, Athreya B, Altshuler SM. Acremonium infection of the esophagus. J Pedtr Gastroenterol Nutr 1997; 24(3): 356-358.
11. Anadolu R, Hilmioglu S, Oskay T, Boyvat A, Peksari Y, Gurgey E. Indolent Acremonium strictum infection in an immunocompetent patient. Int J Dermatol 2001; 40: 451-453.
12. Herbrecht R, Letscher-Bru V, Fohrer C, Campos F, Natarajan-Ame S, Waller J. Acremonium strictum pulmonary infection in a leukemic patient successfully treated with posaconazole after failure of amphotericin B. Eur J Clin Microbiol Infect Dis 2002; 21: 814-817.
13. Lopes JO, Alves SH, Rosa AC, Silva CB, Sarturi JC, Souza AR. Acremonium kiliense peritonitis complicating continuous ambulatory peritoneal dialysis: report of two cases. Mycopathologia 1995; 131: 83-85.
14. Koc AN, Utas C, Oymak O, Sehmen E. Peritonitis due to Acremonium strictum in a patient on continuous ambulatory peritoneal dialysis. Nephron 1998; 79: 357-358.
15. Warris A, Wesenberg F, Gaustad P, Verweij PE, Abrahamsen TG. Acremonium strictum fungemia in a paediatric patient with acute leukaemia. Scand J Infect Dis 2000; 32: 442-444.
16. Koc AN, Erdem F, Paturoglu T. Case report. Acremonium falciforme fungemia in a patient with acute leukaemia. Mycoses 2002; 45: 202-203.
17. Schell WA, Perfect JR. Fatal, disseminated Acremonium strictum infection in a neutropenic host. J Clin Microbiol 1996; 34(5): 1333-1336.
18. Brown NM, Blundell EL, Chown SR, Warnock DW, Hill JA, Slade RR. Acremonium infection in a neutropenic patient. J Infect 1992; 25: 73-76.
19. Roilides E, Bibashi E, Acritidou E, Trahana M, Gompakis N, Karpouzas JC, Koliouskas D. Acremonium fungemia in two immunocompromised children. Pedtr Infect Dis J 1995; 14(6): 548-550.
20. Lau YL, Yuen KY, Lee CW, Chan CF. Invasive Acremonium falciforme infection in a patient with severe combined immunodeficiency. Clin Infect Dis 1995; 20: 197-198.
21. Heitmann L, Cometta A, Hurni M, Aebischer N, Tschan-Schild I, Bille J. Right-sided pacemaker-related endocarditis due to Acremonium species. Clin Infect Dis 1997; 25: 158-159.
22. Noble RC, Salgado J, Newell SW, Goodman NL. Endophthalmitis and lumbar diskitis due to Acremonium falciforme in a splenectomized patient. Clin Infect Dis 1997; 24: 277.
23. Castro LGM, Salebian A, Sotto MN. Hyalohyphomycosis by Paecilomyces lilacinus in a renal transplant patient and a review of human Paecilomyces species infections. J Med Vet Mycol 1990; 28: 15-26.
24. Nayak DR, Balakrishnan R, Nainani S, Siddique S. Paecilomyces fungus infection of the paranasal sinuses. Int J Pedtr Otorhinolaryngol 2000; 52: 183-187.
25. Kovac D, Lindic J, Lejko-Zupanc T, Bren AF, Bojan K, Lesnik M, et al. Treatment of severe Paecilomyces varioti peritonitis in a patient on continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 1998; 13: 2943-2946.
26. Gutierrez-Rodero F, Moragon M, Ortiz de la Tabla V, Mayol MG, Martin C. Cutaneous Hyalohyphomycosis caused by Paecilomyces lilacinus in an immunocompetent host successfully treated with itraconazole: Case report and review. Eur J Clin Microbiol Infect Dis 1999; 18: 814-818.
27. Cohen-Abbo A, Edwards KM. Multifocal osteomyelitis caused by Paecilomyces varioti in a patient with chronic granulomatous disease. Infection 1995; 23(1): 55-57.
28. Williamson PR, Kwon-Chung KJ, Gallin JI. Successful treatment of Paecilomyces varioti infection in a patient with chronic granulomatous disease and a review of Paecilomyces species infections. Clin Infect Dis 1992; 14: 1023-1026.
29. Chan-Tack KM, Thio CL, Miller NS, Karp CL, Ho C, Merz WG. Paecilomyces lilacinus fungemia in an adult bone marrow transplant recipient. Med Mycol 1999; 37: 57-60.
30. Tan TQ, Ogden AK, Tillman J, Demmler GJ, Rinaldi MG. Paecilomyces lilacinus catheter-related fungemia in an immunocompromised pediatric patient. J Clin Microbiol 1992; 30(9): 2479-2483.
31. Gucalp R, Carlisle P, Gialanella P, Mitsudo S, McKitrick J, Dutcher J. Paecilomyces sinusitis in an immunocompromised adult patient: case report and review. Clin Infect Dis 1996; 23: 391-393.
32. Shing MMK, Ip M, Li CK, Chik KW, Yuen PMP. Paecilomyces varioti fungemia in a bone marrow transplant patient. Bone Marrow Transplant 1996; 17: 281-283.
33. Lovell RD, Moll M, Allen J, Cicci LG. Disseminated Paecilomyces lilacinus infection in a patient with AIDS. AIDS Reader 2002; 12: 212-221.
34. Martin CA, Roberts S, Greenberg RN. Voriconazole treatment of disseminated Paecilomyces infection in a patient with acquired immunodeficiency syndrome. Clin Infect Dis 2002; 35: e78-81.
35. Das A, MacLaughlin EF, Ross LA, Monforte HL, Horn MV, Lam GLJ, et al. Paecilomyces variotii in a pediatric patient with lung transplantation. Pedtr Transplant 2000; 4: 328-332.
36. Hilmarsdottir I, Thorsteinsson SB, Asmundsson P, Bodvarsson M, Arnadottir M. Cutaneous infection caused by Paecilomyces lilacinus in a renal transplant patient: treatment with voriconazole. Scand J Infect Dis 2000; 32: 331-332.
37. Diven DG, Newton RC, Sang JL, Beightler EL, McGinnis MR, MacDonald-Davidson E. Cutaneous hyalohyphomycosis caused by Paecilomyces lilacinus in a patient with lymphoma. J Am Acad Dermatol 1996; 35: 779-81.
38. Orth B, Frei R, Itin RH, Rinaldi MG, Speck B, Gratwohl A, et al. Outbreak of invasive mycoses caused by Paecilomyces lilacinus from a contaminated skin lotion. Ann Intern Med 1996; 125: 799-806.
39. Lee J, Yew WW, Chiu CSW, Wong PC, Wong CF, Wang EP. Delayed sternotomy wound infection due to Paecilomyces variotii in a lung transplant recipient. J Heart Lung Transplant 2002; 21: 1131-1134.
40. Athar MA, Sekhon AS, Mcgrath JV, Malone RM. Hyalohyphomycosis caused by Paecilomyces variotii in an obstetrical patient. Eur J Epidemiol 1996; 12(1): 33-35.
41. Young VL, Hertl MC, Murray PR, Lambros VS. Paecilomyces variotii contamination in the lumen of a saline-filled breast implant. Plastic Reconstruct Surg 1995; 96(6): 1430-1434.
42. Marzec A, Heron LG, Pritchard RC, Butcher RH, Powell HR, Disney APS, et al. Paecilomyces variotii in peritoneal dialysate. J Clin Microbiol 1993; 31(9): 2392-2395.
43. Chan TH, Koehler A, Li PKT. Paecilomyces variotti peritonitis in patients on continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1996; 27(1): 138-142.
44. Safdar A. Progressive cutaneous hyalohyphomycosis due to Paecilomyces lilacinus: rapid response to treatment with caspofungin and itraconazole. Clin Infect Dis 2002; 34: 1415-1417.
45. Gottlieb T, Atkins BL. Case report. Successful treatment of cutaneous Paecilomyces lilacinus infection with oral itraconazole in an immune competent host. Mycoses 2000; 44: 513-515.
46. Naidu J, Singh SM. Hyalohyphomycosis caused by Paecilomyces variotii: a case report, animal pathogenicity and 'in vitro' sensitivity. Antonie van Leeuwenhoek 1992; 62: 225-230.
47. Ono N, Sato K, Yokomise H, Tamura K. Lung abscess caused by Paecilomyces lilacinus. Respiration 1999; 66: 85-87.
48. Byrd RD, Roy TM, Fields CL, Lynch JA. Paecilomyces variotii pneumonia in a patient with diabetes mellitus. J Diab Comp 1992; 6: 150-153.
49. Saberhagen C, Klotz SA, Bartholomew W, Drews D, Dixon A. Infection due to Paecilomyces lilacinus: A challenging clinical identification. Clin Infect Dis 1997; 25: 1411-1413.
50. Westenfeld F, Alston WK, Winn WC. Complicated soft tissue infection with prepatellar bursitis caused by Paecilomyces lilacinus in an immunocompetent host: case report and review. J Clin Microbiol 1996; 34(6): 1559-1562.
51. Garbino J, Ondrusova A, Baligvo E, Lew D, Bouchuiguir-Wafa K, Rohner P. Successful treatment of Paecilomyces lilacinus endophthalmitis with voriconazole. Scand J Infect Dis 2002; 34: 701-703.
52. Del Poeta M, Schell WA, Perfect JR. In vitro antifungal activity of pneumocandin L-743,872 against a variety of clinically important molds. Antimicrob Agents Chemother 1997; 41(8): 1835-1836.
53. Aguilar C, Pujol I, Sala J, Guarro J. Antifungal susceptibilities of Paecilomyces species. Antimicrob Agents Chemother 1998; 42(7): 1601-1604.
54. Espinel-Ingroff A. Comparison of in vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts. J Clin Microbiol 1999; 36(10): 2950-2956.
55. Chang HR, Shu KH, Cheng CH, Wu MJ, Chen CH, Lian JD. Peritoneal dialysis associated Penicillium peritonitis. Am J Nephrol 2000; 20: 250-252.
56. Kwon-Chung KJ, Bennett JE. Infections due to miscellaneous molds. Medical Mycology. Philadelphia: Lea & Febiger, 1992: 733-767.
57. Kaufman L. Penicilliosis marneffei and pythiosis: emerging tropical diseases. Mycopathologia 1998; 143: 3-7.
58. Cooper CR, McGinnis MR. Pathology of Penicillium marneffei. An emerging acquired immunodeficiency syndrome-related pathogen. Arch Pathol Lab Med 1997; 121: 798-804.
59. Duong TA. Infection due to Penicillium marneffei, an emerging pathogen: review of 155 reported cases. Clin Infect Dis 1996; 23: 125-130.
60. Hilmarsdottir I, Meynard JL, Rogeaux O, Guermonprez G, Datry A, Katlama C, et al. Disseminated Penicillium marneffei infectionassociated with human immunodeficiency virus: a report of two cases and a review of 35 published cases. J Acquired Immune Deficiency Syndromes 1993; 6: 466-471.
61. Saadiah S, Jeffrey AH, Mohamed AL. Penicillium marneffei infection in a non-AIDS patient: first case report from Malaysia. Med J Malaysia 1999; 54(2): 264-266.
62. Jayanetra P, Nitiyanant P, Ajello L, Padhye AA, Lolekha S, Atichartakam V, et al. Penicilliosis marneffei in Thailand: report of five human cases. Am J Trop Med Hyg 1984; 33(4): 637-644.
63. Heath TCB, Patel A, Fisher D, Bowden FJ, Currie B. Disseminated Penicillium marneffei: Presenting illness of advanced HIV infection; a clinicopathological review, illustrated by a case report. Pathology 1995; 27: 101-105.
64. Hove MGM, Badalamenti J, Woods GL. Penicillium peritonitis in a patient receiving continuous ambulatory peritoneal dialysis. Diagn Microbiol Infect Dis 1996; 25: 97-99.
65. Sekhon AS, Padhye AA, Garg AK. In vitro sensitivity of Penicillium marneffei and Pythium insidiosum to various antifungal agents. Eur J Epidemiol 1992; 8: 427-432.
66. Supparatpinyo K, Chiewchanvit S, Hirunsri P, et al. An efficacy study of itraconazole in the treatment of Penicillium marneffei infection. J Med Assoc Thai 1992; 75: 688-691.
67. Sirisanthana T, Supparatpinyo K, Perriens J, Nelson E. Amphotericin B and itraconazole for treatment of disseminated Penicillium marneffei infection in human immunodeficiency virus-infected patients. Clin Infect Dis 1998; 26: 1107-1110.
68. Supparatpinyo K, Perriens J, Nelson KE, Sirisanthana T. A controlled trial of itraconazole to prevent relapse of Penicillium marneffei infection in patients infected with the human immunodeficiency virus. N Engl J Med 1998; 339(24): 1739-1743.
69. Aguilar C, Pujol I, Guarro J. In vitro antifungal susceptibilities of Scopulariopsis isolates. Antimicrob Agents Chemother 1999; 43(6): 1520-1522.
70. Phillips P, Wood WS, Phillips G, Rinaldi MG. Invasive hyalohyphomycosis caused by Scopulariopsis brevicaulis in a patient undergoing allogeneic bone marrow transplant. Diagn Microbiol Infect Dis 1989; 12: 429-432.
71. de Hoog GS, Guarro J. Atlas of clinical fungi. Baam & Delft, The Netherlands: Centraalburrow voor Schimmelcultures, 1995.
72. Jabor MA, Greer DL, Amedee RG. Scopulariopsis: An invasive nasal infection. Am J Rhinol 1998; 12(5): 367-371.
73. Neglia JP, Hurd DD, Ferrieri P, Snover DC. Invasive Scopulariopsis in the immunocompromised host. Am J Med 1987; 83: 1163-1166.
74. Ellison MD, Hung RT, Harris K, Campbell BH. Report of the first case of invasive fungal sinusitis caused by Scopulariopsis acremonium. Arch Otolaryngol Head Neck Surg 1998; 124: 1014-1016.
75. Kriesel JD, Adderson EE, Gooch III WM, Pavia AT. Invasive sinonasal disease due to Scopulariopsis candida: case report and review of Scopulariopsosis. Clin Infect Dis 1994; 19: 317-319.
76. Ragge NK, Dean Hart JC, Eatsy DL, Tyers AG. A case of fungal keratitis caused by Scopulariopsis brevicaulis: treatment with antifungal agents and penetrating keratoplasty. Br J Ophthalmol 1990; 74: 561-562.
77. Gariano RF, Kalina RE. Posttraumatic fungal endophthalmitis resulting from Scopulariopsis brevicaulis. Retina 1997; 17(3): 256-258.
78. Wheat LJ, Bartlett M, Ciccarelli M, Smith JW. Opportunistic Scopulariopsis pneumonia in an immunocompromised host. South Med J 1984; 77(12): 1608-1609.
79. Endo S, Hironaka M, Murayama F, Yamaguchi T, Sohara Y, Saito K. Scopulariopsis fungus ball. Ann Thorac Surg 2002; 74: 926-927.
80. Migrino RQ, Hall GS, Longworth DL. Deep tissue infections caused by Scopulariopsis brevicaulis: report of a case of prosthetic valve endocarditis and review. Clin Infect Dis 1995; 21: 672-674.
81. Gentry LO, Nasser MM, Kielhofner M. Scopulariopsis endocarditis associated with duran ring vavluloplasty. Tex Heart Inst J 1995; 22: 81-85.
82. Vaidya PS, Levine JF. Scopulariopsis peritonitis in a patient undergoing continuous ambulatory peritoneal dialysis [letter]. Perit Dial Int 1992; 12: 78-79.
83. Sellier P, Monsuez J, Lacroix C, Feray C, Evans J, Minozzi C, et al. Recurrent subcutaneous infection due to Scopulariopsis brevicaulis in a liver transplant recipient. Clin Infect Dis 2000; 30: 820-822.
84. Bruynzeel I, Starink TM. Granulomatous skin infection caused by Scopulariopsis brevicaulis. J Am Acad Dermatol 1998; 39: 365-367.
85. Espinel-Ingroff A, Boyle K, Sheehan DJ. In vitro antifungal activities of voriconazole and reference agents as determined by NCCLS methods: review of the literature. Mycopathologia 2001; 150: 101-115.
86. rd Interscience Conference on Antimicrobial Agents and Chemotherapy (Chicago). 2003. Washington, DC: American Society for Microbiology.